Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines
Euphemia Leung(Cancer Society of New Zealand), Bruce C. Baguley(Maurice Wilkins Centre)
Cited by 27
Related Papers
Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
|Journal of Biomedical Science|2020|98
Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population
|BioMed Research International|2014|46
Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines
|PLoS ONE|2015|45
Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors
|Frontiers in Genetics|2013|43